Sandoz, a subsidiary of Swiss pharmaceutical giant Novartis, has agreed to pay $195 million to avoid trial on charges it conspired to fix prices of generic drugs, US prosecutors announced Monday.
from NDTV News - World-news https://ift.tt/38juDaR
Tuesday, March 3, 2020
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment